BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DNV001 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of DNV001\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07391722-1057@assetmemo.bio
DTSTAMP:20261121T004546Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:DNV001: Phase 2 readout est. (NCT07391722)
DESCRIPTION:DNV001\, phase 2\, Atherosclerotic Cardiovascular Disease.\nStu
 dy: DNV001 Injection in Patients With Hypercholesterolemia\nEstimated prim
 ary completion: 30 June 2027. This is a ClinicalTrials.gov estimate\, not 
 a confirmed readout date\, and it can move.\nDrug page: https://assetmemo.
 bio/drug/dnv001#upcoming-events\nRegistry record: https://clinicaltrials.g
 ov/study/NCT07391722
URL:https://assetmemo.bio/drug/dnv001#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
